[1] 中华人民共和国国家卫生健康委员会.《新型冠状病毒感染的肺炎诊疗方案(试行第八版)》[EB/OL]. [2020-08-18].http://www.nhc.gov.cn/yzygj/s7653p/202008/0a7bdf12bd4b46e5bd28 ca7f9a7f5e5a.shtml [2] 陶悦, 傅启华, 莫茜. 病原宏基因组测序在新型冠状病毒检测中的应用与挑战[J]. 中华检验医学杂志, 2020, 43(3): 217-220. [3] 邓少丽, 刘丁. 新型冠状病毒肺炎的实验室分子诊断及生物安全[J]. 国际检验医学杂志, 2020, 41(12): 1409-1411,1417. [4] 徐万洲, 李娟, 何晓云, 等. 血清2019新型冠状病毒IgM和IgG抗体联合检测在新型冠状病毒感染中的诊断价值[J]. 中华检验医学杂志, 2020, 43(3): 230-233. [5] NAGURA-IKEDA M, IMAI K, TABATA S, et al.Clinical Evaluation of Self-Collected Saliva by Quantitative Reverse Transcription-PCR (RT-qPCR), Direct RT-qPCR, Reverse Transcription-Loop-Mediated Isothermal Amplification, and a Rapid Antigen Test To Diagnose COVID-19[J]. J Clin Microbiol, 2020, 58(9): e01438-20. [6] 王玉珀, 任丽萍. 新型冠状病毒肺炎抗体检测两种方法比较及抗体结果与病程相关性分析[J]. 山西医药杂志, 2021, 50(7): 1068-1070. [7] LISBOA BASTOS M, TAVAZIVA G, ABIDI SK, et al.Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis[J]. BMJ, 2020, 370(6): m2516. [8] LIU W, KOU G, DONG Y, et al.Clinical application of Chemiluminescence Microparticle Immunoassay for 2019-nCoV infection diagnosis[J]. J Clin Virol, 2020, 130(9): 104576. [9] WANG P.Combination of serological total antibody and RT-PCR test for detection of 2019-nCoV infections[J]. J Virol Methods, 2020, 283(9): 113919. [10] FARKA Z, JUíK T, KOVá D, et al. Nanoparticle-Based Immunochemical Biosensors and Assays: Recent Advances and Challenges[J]. Chem Rev, 2017, 117(15): 9973-10042. [11] 杨朝国, 刘继芬, 蒋宏. COVID-19疫苗免疫应答及保护效力研究进展[J]. 中国公共卫生, 2021, 37(05): 896-901. [12] YU S, AN J, LIAO X, et al.Distinct kinetics of immunoglobulin isotypes reveal early diagnosis and disease severity of COVID-19: A 6-month follow-up[J]. Clin Transl Med, 2021, 11(3): e342. [13] 李倩,卢洪洲.新型冠状病毒疫苗研究最新进展[J/CD]. 新发传染病电子杂志, 2020, 5(4): 60-65. [14] 郝鹏飞, 许汪, 杜寿文,等. 冠状病毒起源,受体及新型冠状病毒检测与疫苗最新研究进展[J/CD]. 新发传染病电子杂志, 2020, 5(2):74-78. [15] 廖凡路, 刘艳源, 罗艺, 等. 化学发光法检测新型冠状病毒抗体的临床评价及应用[J]. 武汉大学学报(医学版), 2021, 1(1): 1-4. [16] DEEKS JJ, DINNES J, TAKWOINGI Y, et al. Antibody tests for identification of current and past infection with2019-nCoV[J]. Cochrane Db Syst Rev, 2020, 6(6): CD013652. [17] TZOUVELEKIS A, KARAMPITSAKOS T, KROMPA A, et al.False Positive COVID-19 Antibody Test in a Case of Granulomatosis With Polyangiitis[J]. Front Med-Lausanne, 2020, 7(7): 399. [18] 巢蓓, 范小杰, 姚玉华, 等. 新型冠状病毒特异性抗体检测假阳性分析[J]. 临床检验杂志, 2020, 38(8): 574-577. [19] VERKOOYEN RP, HAZENBERG MA, VAN HAAREN GH, et al.Age-related interference with Chlamydia pneumoniae microimmunofluorescence serology due to circulating rheumatoid factor[J]. J Clin Microbiol, 1992, 30(5): 1287-1290. [20] 王远芳, 邓杰伦, 敖科萍, 等. 三种2019-nCoV抗体胶体金试剂诊断效能评价及假阳性控制策略探讨[J]. 中国呼吸与危重监护杂志, 2020, 19(3): 214-218. [21] 李萍, 李志勇, 赵四林, 等. 血清2019-nCoV IgM和IgG抗体用于诊断新型冠状病毒肺炎的初探[J]. 中华检验医学杂志, 2020, 43(4): 352-357. [22] KHARLAMOVA N, DUNN N, BEDRI SK, et al.False Positive Results in 2019-nCoV Serological Tests for Samples From Patients With Chronic Inflammatory Diseases[J]. Front Immunol, 2021, 12(5): 666114. [23] 肖秀美, 段京京, 吴思沂, 等. 新型冠状病毒IgM和IgG抗体胶体金免疫层析检测的假阳性分析[J]. 中华检验医学杂志, 2020, 43(11): 1080-1085. |